PET MRI Market

Global Market Study on PET MRI - The Next Leg of Growth for Hybrid Imaging Equipment Manufacturers

PET MRI Market is segmented by Product Type, PET Imaging Technology, Image Acquisition, Applications, End-User

  • April-2019
  • PMRREP28201
  • 281 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Integrated PET MRI Scanners Hold Significant Revenue Share in the Market

In oncology, staging forms the basis for prognostic consideration and directly influences patient care by determining the therapeutic approach. After the successful introduction of PET/CT, the search for appropriate PET/MRI instrumentation as another bimodal imaging tool was intensified.

With first prototypes of a 3T PET MRI scanner for brain imaging equipped with APDs, Siemens brought out a full-body integrated PET/MRI scanner at 3T using the same technology in 2010. These integrated PET MRI scanners are expected to remain a prominent component of the PET MRI market as these products are able to acquire images simultaneously for diagnostic purpose, thus being preferred for clinical purposes.

On the other hand, the adoption of PET inserts is expected to grow at a significant rate due to their cost effectiveness for pre-clinical research and increasing acceptance by biopharmaceutical companies, which carry out extensive preclinical studies in animal models.

Find Out More about the Report Coverage

Companies

  • GE Healthcare
  • Siemens AG
  • Koninklijke Philips N.V.
  • United Imaging
  • Bruker
  • Mediso Ltd.
  • Aspect Imaging
  • Cubresa Inc.
  • inviscan SAS
  • MR Solutions

Synchronization of Screening Techniques to Aid Patient Comfort

Manufacturers of PET MRI scanners are shifting to technologies and product specifications that tend to consume lesser efforts for production and offer non-invasive diagnosis, reliability of the screening results, as well as testing with lesser tracer doses and low ionizing radiation exposure as experienced in PET/CT scanners or invasive staging procedures like biopsy.

Workflow management which was considered as an impeding factor in functioning of conventional modalities like PET/CT or sequential PET/MRI scanners due to necessity of moving patients from one device to another is overcome.  

Technological advancements in tracers have led to the requirement of lesser quantity of tracer doses and quicker results are expected to be ensure convenience for people already suffering from various kinds of dementia. Features like these are anticipated to provide added incentives for healthcare professionals to opt for PET MRI-based imaging.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

R&D Funds for Research Institutes to Increase Demand for PET MRI Scanners

The increasing burden of incurable and rare diseases has resulted in an unmet need for multi-modal imaging techniques, which aid in understanding the mechanism of disease progression. The demand from researchers for newly available modality is increasing the installation of PET MRI in research institutes.

For instance, European Institute for Biomedical imaging (EIBIR) coordinated along with 10 partners, on a funding of €5,861,957 for a project named Digital Hybrid Breast PET/MRI for Enhanced Diagnosis of Breast Cancer (HYPMED). The HYPMED project is a four-year project aimed at developing a hybrid system of two medical imaging modalities (MRI and PET) for improved diagnosis of breast cancer and personalized therapy control.

pet mri market

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Need Gap Exists for Large Number of Patients as Selected Diagnostic Facilities offer PET MRI Currently

According to WHO’s GLOBOCAN 2018 database, the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. One in 5 men and one in 6 women worldwide develop cancer during their lifetime.

The patients with rare form of ulcers, lesions and tumors are required to undergo PET/MRI screening to confirm occurrence and recurrence of disease. Rising prevalence of congenital cardiac disorders, oncological onset, traumatic injuries post-surgery, and inflammation which cannot be diagnosed with any other modality have led to the installation of PET MRI scanners in hospitals for clinical purposes. On the other hand, limited number of PET MRI scanners prove to be an opportunity for manufacturers to enter the highly consolidated PET MRI market.

Explore Persistence Market Research’s expertise in promulgation of the business !

Edge over Traditional Configuration and Modalities

Functional attributes of PET MRI position them above other conventional diagnostic devices available in the market, such as X-ray, ultrasound, CT scan, standalone PET or MRI, PET-CT in terms of ease and convenience. Hence, it is expected that the former will continue to gain preference despite the significantly large utilization of conventional imaging methods.

PET MRI are used in the diagnosis of numerous oncological conditions including tumors of brain, head, neck, chest, abdomen, pelvis, bone, soft-tissues, and malignancies like melanoma and lymphoma.

Innovative Technological Upgradations with Increasing Frequency

The introduction of new hardware designs, technologies, and software has been directing the focus of manufacturers towards development of devices with advanced technical characteristics such as SUVmax, axial/transaxial field of view, avalanche photodiodes, silicon photomultipliers, and PET inserts that can be accommodated within a MRI gantry to enable concurrent image acquisitions.

Unique Functionality of PET MRI to Lend Imperatives to Oncologists

From diagnosis to prognosis, PET MRI scan results decide the treatment to be suggested by a healthcare provider. Moreover, TNM staging of cancer by nuclear medicine expert or radiologist can be fruitful when malignancy makes it cumbersome to detect tumors, which spread throughout the body.

Localization of lesions, tumor characterization, post-therapy scar, and radiotracer efficiency are some of the topics of clinical studies within oncology that lend imperatives to oncologists.

Highly Capital Intensive Product Development Resulting in Top-Heavy Competition Landscape

GE Healthcare, Siemens AG, and Koninklijke Philips are the three top players operating in the PET MRI market. Top players in the market are expected to hold approximately 85% of the revenue share in the overall market during the forecasted period. Other players present in the market are focused on collaboration with top players to supply components.

Another approach followed by players is research collaboration with leading research institutes. For example, Cubresa Inc., the PET insert company, signed an agreement with Department of Medical Imaging and the University of Arizona BIO5™ Institute in order to fully exploit a unique MRI method and the synthesis of contrast agents that relies on patented technology from Pagel’s lab to measure a tumor’s acidity.

Analyst’s Viewpoint

Increasing acceptance of PET MRI scanners, especially in developed countries like the U.S, Japan, and Germany is spurring the growth of the global PET MRI market. Furthermore, the higher adoption of PET Inserts for pre-clinical applications is more likely to support the growth of the PET MRI market over the forecast period.

The PET MRI market is expected to have a robust growth in the forecast period owing to new screening techniques, equipment design, innovative product launches through international conferences and collaborative associations

Key Segments of the PET MRI Market

PMR’s study on the PET MRI market offers information divided into six important segments - Product Type, PET Imaging Technology, Image Acquisition, Applications, End User and by Region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type
  • Integrated
  • Separate
  • Insert
  • Hybrid
PET Imaging Technology
  • Conventional
  • Time of Flight
Image Acquisition
  • Sequential PET MRI Scanners
  • Simultaneous PET MRI Scanners
Applications
  • Preclinical PET MRI Systems
  • Clinical PET MRI Systems
End User
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Biopharmaceutical Co.
Region
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle-East & Africa

Key Questions Answered in PMR’s PET MRI Market Report

  • Which regions will continue to remain the most profitable regional markets for PET MRI market players?
  • Which factors will induce a change in the demand for PET MRI manufacturers during the assessment period?
  • How will changing trends impact the PET MRI market?
  • How can market players capture the low-hanging opportunities in the PET MRI market in developed regions?
  • Which companies are leading the PET MRI market?
  • What are the winning strategies of stakeholders in the PET MRI market to upscale their position in this landscape?

Media Release

Recommendations

Surgical Imaging Market

Global Surgical Imaging Market is projected to bring in nearly US$ 900 million in revenue along with a healthy CAGR by the year 2026 end. Detail inside.

Metastatic Melanoma Cancer Diagnostics Market

The global metastatic melanoma cancer diagnostics market is estimated to be valued at US$ 2.9 Bn in 2021, and exhibit a CAGR of close to 8% over the forecast period (2021 – 2031)..

Intra Operative Imaging Market

Global intraoperative imaging market by 2016 end and is expected to gain 30 bps in its market share by 2024 over 2016 & is expected to reach a market valuation of US$ 800 Mn.

Advanced Computed Tomography Scanners Market

Global market has witnessed positive yet slow growth since 2012 and is expected to register a high value CAGR of 7.9% with a healthy revenue throughout the forecast.

Our Clients

Our Clients